Stock A204840 GL PHARM TECH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company GL Pharm Tech Corp.

Equities

A204840

KR7204840003

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 02/05/2024 BST 		5-day change 1st Jan Change
1,226 KRW -2.70% Intraday chart for GL Pharm Tech Corp. -7.12% +7.92%
03-06 W Science Co., Ltd. completed the acquisition of 14.75% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund CI
03-06 GL Pharm Tech Corp. announced that it has received KRW 9.199999458 billion in funding from W Science Co., Ltd. CI

Business Summary

GL Pharm Tech Corp., formerly IBKS No.2 Special Purpose Acquisition Company, is a Korea-based company mainly engaged in the research and development of pharmaceutical products.

Number of employees: 22

Sales per Business

KRW in Million2022Weight2023Weight Delta
Drug Development Technology Product
90.3 %
14,665 87.7 % 23,505 90.3 % +60.28%
Research Service
6.5 %
1,381 8.3 % 1,692 6.5 % +22.49%
Royalty
3.2 %
682 4.1 % 835 3.2 % +22.45%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
16,729 100.0 % 26,033 100.0 % +55.62%

Managers

Managers TitleAgeSince
Hun-Sik Wang CEO
 Chief Executive Officer 52 31/07/02
Jun-Sang Park CTO
 Chief Tech/Sci/R&D Officer 52 31/07/02
Dae-Jong Park AUD
 Comptroller/Controller/Auditor 51 31/10/15

Members of the board

Members of the board TitleAgeSince
Hun-Sik Wang CEO
 Chief Executive Officer 52 31/07/02
Jun-Sang Park CTO
 Chief Tech/Sci/R&D Officer 52 31/07/02
Jae-Kyung Park BRD
 Director/Board Member - -
Dong-Hwan Kim BRD
 Director/Board Member 48 -
Yong-Beom Kim BRD
 Director/Board Member 44 29/03/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 76,699,394 59,311,466 ( 77.33 %) 20 ( 0.000026 %) 77.33 %

Shareholders

NameEquities%Valuation
HLB SCIENCE INC.
26.27 %
20,147,479 26.27 % 20 M ₩
KC CO., LTD.
4.048 %
3,104,992 4.048 % 3 M ₩
Ideal Private Equity Co., Ltd.
3.383 %
2,594,472 3.383 % 3 M ₩
Jun-Sang Park
2.472 %
1,896,326 2.472 % 2 M ₩
Hun-Sik Wang
1.295 %
993,323 1.295 % 1 M ₩
Ji-yun Shim
0.2854 %
218,938 0.2854 % 221 662 ₩
Eun-jung Kim
0.1612 %
123,609 0.1612 % 125 147 ₩
Dae-Jong Park
0.0971 %
74,442 0.0971 % 75 368 ₩
GL PHARM TECH CORP.
0.000026 %
20 0.000026 % 20 ₩

Holdings

NameEquities%Valuation
GL PHARM TECH CORP.
0.00%
 20 0.00% 20 $

Company contact information

GL Pharm Tech Corp.

Unit 714, Jungang Induspia Wing 5 137 Sagimakgol-ro

13202, Seongnam-si

+

http://www.glpt.co.kr
address GL Pharm Tech Corp.(A204840)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
GL PHARM TECH CORP. Stock GL Pharm Tech Corp.
+7.92% 69.41M
MODERNA, INC. Stock Moderna, Inc.
+25.69% 47.9B
LONZA GROUP AG Stock Lonza Group AG
+46.90% 41.42B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-3.46% 40.7B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.92B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+9.17% 25.55B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.42% 19.27B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.17% 12.15B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.07% 12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.24% 11.99B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A204840 Stock
  4. Company GL Pharm Tech Corp.